Results 41 to 50 of about 419,747 (259)

A Case of Neisseria sicca Bacteremia Due to Eculizumab Therapy

open access: yesAnnals of Internal Medicine: Clinical Cases, 2023
Eculizumab is a monoclonal antibody indicated for the treatment of complement-mediated disorders. Despite its utility, eculizumab increases risk for infection with Neisseria species, owing to membrane attack complex inhibition.
Kelly A. Russo, Ted Louie
doaj   +1 more source

Premature Drug Release from Polyethylene Glycol (PEG)-Coated Liposomal Doxorubicin via Formation of the Membrane Attack Complex.

open access: yesACS Nano, 2020
Anti-polyethylene glycol (PEG) antibodies are present in many healthy individuals as well as in patients receiving polyethylene glycol-functionalized drugs.
Even Chen   +6 more
semanticscholar   +1 more source

Clinical Isolates of Acinetobacter spp. Are Highly Serum Resistant Despite Efficient Recognition by the Complement System

open access: yesFrontiers in Immunology, 2022
Gram-negative bacteria from the genus Acinetobacter are responsible for life-threating hospital-related infections such as pneumonia, septicemia, and meningitis, especially in immunocompromised patients.
Michal Magda   +6 more
doaj   +1 more source

Astrocyte- and Neuron-Derived Extracellular Vesicles from Alzheimer’s Disease Patients Effect Complement-Mediated Neurotoxicity

open access: yesCells, 2020
We have previously shown that blood astrocytic-origin extracellular vesicles (AEVs) from Alzheimer’s disease (AD) patients contain high complement levels.
Carlos J. Nogueras-Ortiz   +9 more
doaj   +1 more source

Complement-5 Inhibition Deters Progression of Fulminant Hepatitis to Acute Liver Failure in Murine ModelsSummary

open access: yesCellular and Molecular Gastroenterology and Hepatology, 2021
Background & Aims: Acute liver failure (ALF) is a life-threatening condition with limited treatment alternatives. ALF pathogenesis seemingly involves the complement system. However, no complement-targeted intervention has been clinically applied.
Jiro Kusakabe   +11 more
doaj   +1 more source

Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets. [PDF]

open access: yesPLoS ONE, 2011
The activation of complement during platelet activation is incompletely understood.We sought to explore the formation of C5b-9 and anaphylatoxins binding to collagen-activated platelets.C5b-9, anaphylatoxins C3a, C4a and C5a, and anaphylatoxin receptors ...
Catherine Martel   +6 more
doaj   +1 more source

Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models

open access: yesActa Neuropathologica Communications, 2022
Complement is involved in developmental synaptic pruning and pathological synapse loss in Alzheimer’s disease. It is posited that C1 binding initiates complement activation on synapses; C3 fragments then tag them for microglial phagocytosis. However, the
Sarah M. Carpanini   +10 more
doaj   +1 more source

Soluble MAC is primarily released from MAC-resistant bacteria that potently convert complement component C5

open access: yeseLife, 2022
The membrane attack complex (MAC or C5b-9) is an important effector of the immune system to kill invading microbes. MAC formation is initiated when complement enzymes on the bacterial surface convert complement component C5 into C5b.
Dennis J Doorduijn   +7 more
doaj   +1 more source

Research progress of perforin 2 [PDF]

open access: yesJichu yixue yu linchuang
Perforin 2 (MPEG 1) is a member of the MACPF(membrane attack complex/PRF membrane attack complex/perforin) superfamily, which is mainly secreted by cytotoxic T lymphocytes, natural killer cells and macrophages Through the formation of active pores on the
DENG Zhiyuan, BAI Lu, YU Rong
doaj   +1 more source

Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice

open access: yesJournal of Neuroinflammation, 2010
Background The complement system is a crucial mediator of inflammation and cell lysis after cerebral ischemia. However, there is little information about the exact contribution of the membrane attack complex (MAC) and its inhibitor-protein CD59.
Nietfeld Wilfried   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy